West Pharmaceutical Services Inc

Medical Instruments & Supplies

Prices are adjusted according to historical splits.

West Pharmaceutical Services Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$25.52 billion
Book Value:
Revenue TTM:
$2.88 billion
Operating Margin TTM:
Gross Profit TTM:
$1.14 billion
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

West Pharmaceutical Services Inc had its IPO on 1978-01-13 under the ticker symbol WST.

The company operates in the Healthcare sector and Medical Instruments & Supplies industry. West Pharmaceutical Services Inc has a staff strength of 10,700 employees.

Stock update

Shares of West Pharmaceutical Services Inc opened at $342.69 at the start of the last trading session i.e. 2023-06-03.

The stocks traded within a range of $339.99 - $343.93, and closed at $343.73.

This is a +0.64% increase from the previous day's closing price.

A total volume of 385,900 shares were traded at the close of the day’s session.

In the last one week, shares of West Pharmaceutical Services Inc have increased by +0.9%.

West Pharmaceutical Services Inc's Key Ratios

West Pharmaceutical Services Inc has a market cap of $25.52 billion, indicating a price to book ratio of 7.1615 and a price to sales ratio of 6.0336.

In the last 12-months West Pharmaceutical Services Inc’s revenue was $2.88 billion with a gross profit of $1.14 billion and an EBITDA of $864.80 million. The EBITDA ratio measures West Pharmaceutical Services Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, West Pharmaceutical Services Inc’s operating margin was 25.74% while its return on assets stood at 13.22% with a return of equity of 21.64%.

In Q1, West Pharmaceutical Services Inc’s quarterly earnings growth was a negative -19.2% while revenue growth was a negative 0.5%.

West Pharmaceutical Services Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $7.27 per share while it has a forward price to earnings multiple of 28.8184 and a PEG multiple of 4.0596. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into West Pharmaceutical Services Inc’s profitability.

West Pharmaceutical Services Inc stock is trading at a EV to sales ratio of 5.9352 and a EV to EBITDA ratio of 19.9417. Its price to sales ratio in the trailing 12-months stood at 6.0336.

West Pharmaceutical Services Inc stock pays annual dividends of $0.74 per share, indicating a yield of 0.22% and a payout ratio of 9.09%.

Balance sheet and cash flow metrics

Total Assets
$3.72 billion
Total Liabilities
$534.90 million
Operating Cash Flow
Capital Expenditure
$82.10 million
Dividend Payout Ratio

West Pharmaceutical Services Inc ended 2023 with $3.72 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $3.72 billion while shareholder equity stood at $2.78 billion.

West Pharmaceutical Services Inc ended 2023 with $33.50 million in deferred long-term liabilities, $534.90 million in other current liabilities, 18800000.00 in common stock, $3.11 billion in retained earnings and $107.80 million in goodwill. Its cash balance stood at $886.30 million and cash and short-term investments were $886.30 million. The company’s total short-term debt was $18,400,000 while long-term debt stood at $206.10 million.

West Pharmaceutical Services Inc’s total current assets stands at $1.94 billion while long-term investments were $208.80 million and short-term investments were $0. Its net receivables were $513.40 million compared to accounts payable of $233.80 million and inventory worth $447.00 million.

In 2023, West Pharmaceutical Services Inc's operating cash flow was $-82100000.00 while its capital expenditure stood at $82.10 million.

Comparatively, West Pharmaceutical Services Inc paid $0.09 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

West Pharmaceutical Services Inc stock is currently trading at $343.73 per share. It touched a 52-week high of $376.72 and a 52-week low of $376.72. Analysts tracking the stock have a 12-month average target price of $369.22.

Its 50-day moving average was $353.07 and 200-day moving average was $287.39 The short ratio stood at 2 indicating a short percent outstanding of 0%.

Around 52.6% of the company’s stock are held by insiders while 9505.5% are held by institutions.

Frequently Asked Questions About West Pharmaceutical Services Inc

The stock symbol (also called stock or share ticker) of West Pharmaceutical Services Inc is WST

The IPO of West Pharmaceutical Services Inc took place on 1978-01-13

Similar Industry Stocks (Medical Instruments & Supplies)

Last Price

Most Active

Last Price
Zomato Limited (ZOMATO)
Tesla Inc (TSLA)
Yes Bank Limited (YESBANK)

Top Gainers

Last Price
AEye Inc (LIDRW)

Top Losers

Last Price


West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.


530 Herman O. West Drive, Exton, PA, United States, 19341-0645